project id: TCGA-KIRC; case submitter id: TCGA-B8-A54J; analyte type: DNA; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.58; rna integrity number: 8.8; age at index: 60; days to birth: -22071; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1952; age at diagnosis: 22071; ajcc clinical m: M0; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage II; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 528.0; icd 10 code: C64.9; last known disease status: not reported; morphology: 8312/3; primary diagnosis: Renal cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 82; days to sample procurement: 0; initial weight: 710.0; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0;